Inflammation and neuro-immune dysregulations in autism spectrum disorders D Siniscalco, S Schultz, AL Brigida, N Antonucci Pharmaceuticals 11 (2), 56, 2018 | 277 | 2018 |
Intestinal dysbiosis and yeast isolation in stool of subjects with autism spectrum disorders MR Iovene, F Bombace, R Maresca, A Sapone, P Iardino, A Picardi, ... Mycopathologia 182, 349-363, 2017 | 174 | 2017 |
The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption F Rossi, D Siniscalco, L Luongo, L De Petrocellis, G Bellini, S Petrosino, ... Bone 44 (3), 476-484, 2009 | 165 | 2009 |
Role of reactive oxygen species and spinal cord apoptotic genes in the development of neuropathic pain D Siniscalco, C Fuccio, C Giordano, F Ferraraccio, E Palazzo, L Luongo, ... Pharmacological research 55 (2), 158-166, 2007 | 134 | 2007 |
Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice D Siniscalco, C Giordano, U Galderisi, L Luongo, V de Novellis, F Rossi, ... Frontiers in integrative neuroscience 5, 79, 2011 | 131 | 2011 |
Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders D Siniscalco, A Sapone, C Giordano, A Cirillo, L de Magistris, F Rossi, ... Journal of autism and developmental disorders 43, 2686-2695, 2013 | 126 | 2013 |
Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice D Siniscalco, C Giordano, U Galderisi, L Luongo, N Alessio, ... Cellular and Molecular Life Sciences 67, 655-669, 2010 | 122 | 2010 |
Role of neurotrophins in neuropathic pain D Siniscalco, C Giordano, F Rossi, S Maione, V de Novellis Current neuropharmacology 9 (4), 523-529, 2011 | 120 | 2011 |
AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain B Costa, D Siniscalco, AE Trovato, F Comelli, ML Sotgiu, M Colleoni, ... British journal of pharmacology 148 (7), 1022-1032, 2006 | 119 | 2006 |
A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice C Fuccio, C Luongo, P Capodanno, C Giordano, MA Scafuro, ... European journal of pharmacology 603 (1-3), 42-49, 2009 | 117 | 2009 |
Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency-mediated chronic pain F Guida, S Boccella, C Belardo, M Iannotta, F Piscitelli, F De Filippis, ... Brain, behavior, and immunity 85, 128-141, 2020 | 106 | 2020 |
Antibodies against food antigens in patients with autistic spectrum disorders L de Magistris, A Picardi, D Siniscalco, MP Riccio, A Sapone, R Cariello, ... BioMed research international 2013 (1), 729349, 2013 | 104 | 2013 |
The A1 adenosine receptor as a new player in microglia physiology L Luongo, F Guida, R Imperatore, F Napolitano, L Gatta, L Cristino, ... Glia 62 (1), 122-132, 2014 | 103 | 2014 |
TRPV1-dependent and-independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception C Giordano, L Cristino, L Luongo, D Siniscalco, S Petrosino, F Piscitelli, ... Cerebral cortex 22 (11), 2495-2518, 2012 | 103 | 2012 |
Blockade of glutamate mGlu5 receptors in a rat model of neuropathic pain prevents early over-expression of pro-apoptotic genes and morphological changes in dorsal horn lamina II V de Novellis, D Siniscalco, U Galderisi, C Fuccio, M Nolano, L Santoro, ... Neuropharmacology 46 (4), 468-479, 2004 | 103 | 2004 |
Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels F Rossi, S Perrotta, G Bellini, L Luongo, C Tortora, D Siniscalco, ... Haematologica 99 (12), 1876, 2014 | 101 | 2014 |
Epigenetic findings in autism: new perspectives for therapy D Siniscalco, A Cirillo, JJ Bradstreet, N Antonucci International Journal of Environmental Research and Public Health 10 (9 …, 2013 | 98 | 2013 |
Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease B D'Agostino, N Sullo, D Siniscalco, A De Angelis, F Rossi Expert opinion on biological therapy 10 (5), 681-687, 2010 | 89 | 2010 |
Peripheral inflammatory markers contributing to comorbidities in autism MC Inga Jácome, LM Morales Chacòn, H Vera Cuesta, C Maragoto Rizo, ... Behavioral Sciences 6 (4), 29, 2016 | 85 | 2016 |
Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future? D Siniscalco, A Sapone, A Cirillo, C Giordano, S Maione, N Antonucci BioMed Research International 2012 (1), 480289, 2012 | 82 | 2012 |